Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshihiko Ando

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Hematology (Amsterdam, Netherlands)|November 3, 2022
Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemiaHiroshi Ureshino, Kazuharu Kamachi, Haruhiko Sano, et al.
Hematological Oncology|June 12, 2021
Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experienceHiroshi Ureshino, Kazuharu Kamachi, Atsujiro Nishioka, et al.
Internal Medicine (Tokyo, Japan)|September 16, 2016
Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaHiroshi Ureshino, Atsujiro Nishioka, Kensuke Kojima, et al.
World Journal of Orthopedics|January 2, 2025
Prognostic factors in patients with bone metastasis of lung cancer after immune checkpoint inhibitors: A retrospective studyYuki Ishibashi, Hiroshi Kobayashi, Toshihiko Ando, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 2, 2006
[All-trans retinoic acid-induced erythema nodosum in acute promyelocytic leukemia]Akihiko Taguchi, Toru Takahashi, Youhei Harima, et al.
British Journal of Haematology|October 24, 2006
Elevation of serum high-mobility group box 1 protein during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilisationKozo Tagami, Toshiaki Yujiri, Atsuko Tanimura, et al.
European Journal of Haematology|January 19, 2005
Autografting followed by a reduced-intensity conditioning unrelated donor cord blood transplantation for a patient with refractory multiple myeloma: successful engraftment with minimal toxicityToshihiko Ando, Toshiaki Yujiri, Takayuki Tominaga, et al.
International Journal of Hematology|January 30, 2020
Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapyHiroshi Ureshino, Shuichi Koarada, Kazuharu Kamachi, et al.
Internal Medicine (Tokyo, Japan)|December 16, 2015
Rituximab-containing Chemotherapy (R-CHOP)-induced Kaposi's Sarcoma in an HIV-negative Patient with Diffuse Large B Cell LymphomaHiroshi Ureshino, Toshihiko Ando, Kensuke Kojima, et al.
International Journal of Hematology|December 4, 2016
5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10)Hiroshi Ureshino, Haruna Kizuka, Kana Kusaba, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Hematology (Amsterdam, Netherlands)|November 3, 2022
Higher neutrophil counts are associated with successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemiaHiroshi Ureshino, Kazuharu Kamachi, Haruhiko Sano, et al.
Hematological Oncology|June 12, 2021
Subsequent attempt tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia; a single institute experienceHiroshi Ureshino, Kazuharu Kamachi, Atsujiro Nishioka, et al.
Internal Medicine (Tokyo, Japan)|September 16, 2016
Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic LeukemiaHiroshi Ureshino, Atsujiro Nishioka, Kensuke Kojima, et al.
World Journal of Orthopedics|January 2, 2025
Prognostic factors in patients with bone metastasis of lung cancer after immune checkpoint inhibitors: A retrospective studyYuki Ishibashi, Hiroshi Kobayashi, Toshihiko Ando, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 2, 2006
[All-trans retinoic acid-induced erythema nodosum in acute promyelocytic leukemia]Akihiko Taguchi, Toru Takahashi, Youhei Harima, et al.
British Journal of Haematology|October 24, 2006
Elevation of serum high-mobility group box 1 protein during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilisationKozo Tagami, Toshiaki Yujiri, Atsuko Tanimura, et al.
European Journal of Haematology|January 19, 2005
Autografting followed by a reduced-intensity conditioning unrelated donor cord blood transplantation for a patient with refractory multiple myeloma: successful engraftment with minimal toxicityToshihiko Ando, Toshiaki Yujiri, Takayuki Tominaga, et al.
International Journal of Hematology|January 30, 2020
Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapyHiroshi Ureshino, Shuichi Koarada, Kazuharu Kamachi, et al.
Internal Medicine (Tokyo, Japan)|December 16, 2015
Rituximab-containing Chemotherapy (R-CHOP)-induced Kaposi's Sarcoma in an HIV-negative Patient with Diffuse Large B Cell LymphomaHiroshi Ureshino, Toshihiko Ando, Kensuke Kojima, et al.
International Journal of Hematology|December 4, 2016
5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10)Hiroshi Ureshino, Haruna Kizuka, Kana Kusaba, et al.
Pageof 8